Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
Public ClinicalTrials.gov record NCT02581345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-blind, Multicenter Study to Evaluate Efficacy, Safety, and Immunogenicity of an Adalimumab Biosimilar (M923) and Humira® in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate efficacy, safety, and immunogenicity of a proposed adalimumab biosimilar (M923) and Humira in participants with moderate to severe chronic plaque-type psoriasis.
Study identification
- NCT ID
- NCT02581345
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 572 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2015 (Type not available)
- Primary completion
- Apr 4, 2017 (Actual)
- Completion
- Apr 4, 2017 (Actual)
- Last update posted
- Oct 17, 2018
2015 – 2017
United States locations
- U.S. sites
- 24
- U.S. states
- 11
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wallace Medical Group, Inc. | Beverly Hills | California | 90211 | — |
| Encino Research Center | Encino | California | 91436 | — |
| eStudySite | La Mesa | California | 91942 | — |
| eStudySite | Oceanside | California | 92056 | — |
| eStudySite | San Diego | California | 92120 | — |
| Shahram Jacobs MD, INC | Sherman Oaks | California | 91403 | — |
| Horizons Clinical Research Center, LLC | Denver | Colorado | 80220 | — |
| Bioclinical Research Alliance; Inc | Miami | Florida | 33155 | — |
| Sanitas Reasearch, LLC | Miami | Florida | 33155 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Compass Research, LLC | Orlando | Florida | 32806 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| Radiant Research; Inc. | Overland Park | Kansas | 66210 | — |
| Tufts Medical Center; Inc. | Boston | Massachusetts | 02111 | — |
| Bay State Clinical Trials, Inc | Watertown | Massachusetts | 02472 | — |
| eStudySite | Las Vegas | Nevada | 89109 | — |
| Radiant Research; Inc. | Cincinnati | Ohio | 45249 | — |
| Radiant Research, Inc. | Columbus | Ohio | 43212 | — |
| Radiant Clinical Research | Anderson | South Carolina | 29621 | — |
| Palmetto Clinical Trial Services, LLC | Fountain Inn | South Carolina | 29644 | — |
| Radiant Research, Inc. | Greer | South Carolina | 29650 | — |
| Austin Institute for Clinical Research, LLC | Pflugerville | Texas | 78660 | — |
| Clinical Trials of Texas; Inc. | San Antonio | Texas | 78229 | — |
| National Clinical Research-Richmond, Inc | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02581345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2018 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02581345 live on ClinicalTrials.gov.